We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byDebra Conley
Modified over 4 years ago
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival Elizabeth A. David, MD, Robert J. Canter, MD, MAS, Yingjia Chen, MPH, David T. Cooke, MD, Rosemary D. Cress, DrPH The Annals of Thoracic Surgery Volume 102, Issue 4, Pages (October 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Distribution of treatment groups overall and by stage: (A) entire cohort; (B) stage IIIA; (C) stage IIIB; and (D) stage IV. (Chemo = chemotherapy; Rad = radiation; Surg = surgery.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Distribution of treatment groups by year: (A) stage IIIA; (B) stage IIIB; and (C) stage IV. **Denotes trend is significant (p < 0.05). (Blue line = chemotherapy only; red line = chemotherapy and radiation; green line = surgery, chemotherapy, and radiation; purple line = chemotherapy and surgery; teal line = surgery only; orange = surgery and radiation; light blue line = radiation only; pink line = no treatment; light green line = unknown.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier plots for overall survival: (A) entire cohort; (B) stage IIIA; (C) stage IIIB; and (D) stage IV. Hatchmarks indicate censored; log rank p less than (Chemo = chemotherapy; CR = chemotherapy and radiation; CRS = chemotherapy, radiation, surgery; CS = chemotherapy and surgery; NTx = no treatment; Rad = radiation; SURG = surgery.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Su K. Metcalfe, MD, MPH, Michael T
Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Benny Weksler, MD, Jennifer L. Sullivan, MD
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Chun Chieh Lin, PhD, MBA, Matthew P
Joshua E. Rosen, BASc, Hari B
Ravi Rajaram, MD, MSc, Jennifer L
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Matthew D. Taylor, MD, Alykhan S. Nagji, MD, Castigliano M
Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD
Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer Talha Shaikh,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
© 2023 SlidePlayer.com Inc. All rights reserved.